Besson, C. (2022) “It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies”, Haematologica. Pavia, Italy, 107(3), pp. 572-573. doi: 10.3324/haematol.2021.279457.